Literature DB >> 17950328

Identification of differentially expressed genes in microsatellite stable HNPCC and sporadic colon cancer.

Won-Suk Lee1, Gilju Seo, Hee Jung Shin, Seong Hyeon Yun, Haeran Yun, Naeyun Choi, Jinseon Lee, Daesoon Son, Jisook Cho, Jhingook Kim, Yong Beom Cho, Ho-Kyung Chun, Woo Yong Lee.   

Abstract

BACKGROUND: Some sporadic colon cancers and hereditary nonpolyposis colorectal cancer (HNPCC) have been known by a constitutional defect in mismatch gene repair (MMR) and dysfunction in of this MMR system, which lead to an aberrant phenotype that can cause microsatellite instability. However, the clinicopathologic features of still existing microsatellite stable (MSS) colon cancer remain to be investigated.
METHOD: We compared the gene expression patterns of nine tumor tissues of HNPCC and nine tumor tissues of sporadic colon cancer with their adjacent pathologically normal, MSS tissues by modified differential display-polymerase chain reaction, selected four potential marker genes, and confirmed their reproducibility by reverse transcriptase-polymerase chain reaction.
RESULTS: Reg I, MLCK, and MYH11 in tumors of MSS HNPCC showed significant differences in gene expression pattern compared with the adjacent pathologically normal tissues (P = 0.028, P = 0.002, and P = 0.001, respectively). Similar differences in expression patterns for the same set of genes were seen between the sporadic colon cancer group and their adjacent pathologically normal tissues (P = 0.012, P = 0.003, and P = 0.002, respectively).
CONCLUSION: We suggest that the three cancer-associated differentially expressed genes in MSS sporadic colon cancer or MSS HNPCC might be potential tumor markers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950328     DOI: 10.1016/j.jss.2007.02.005

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  12 in total

1.  Epigenetic regulation of REG1A and chemosensitivity of cutaneous melanoma.

Authors:  Yusuke Sato; Diego M Marzese; Katsuya Ohta; Sharon K Huang; Myung Shin Sim; Kelly Chong; Dave S B Hoon
Journal:  Epigenetics       Date:  2013-07-31       Impact factor: 4.528

2.  mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.

Authors:  Bianca Mostert; Anieta M Sieuwerts; Joan Bolt-de Vries; Jaco Kraan; Zarina Lalmahomed; Anne van Galen; Petra van der Spoel; Vanja de Weerd; Raquel Ramírez-Moreno; Marcel Smid; Cornelis Verhoef; Jan N M IJzermans; Jan W Gratama; Stefan Sleijfer; John A Foekens; John W M Martens
Journal:  Mol Oncol       Date:  2015-01-21       Impact factor: 6.603

3.  Identifying the tumor location-associated candidate genes in development of new drugs for colorectal cancer using machine-learning-based approach.

Authors:  Tuncay Bayrak; Zafer Çetin; E İlker Saygılı; Hasan Ogul
Journal:  Med Biol Eng Comput       Date:  2022-08-10       Impact factor: 3.079

Review 4.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

Review 5.  The actin cytoskeleton in cancer cell motility.

Authors:  Michael F Olson; Erik Sahai
Journal:  Clin Exp Metastasis       Date:  2008-05-23       Impact factor: 5.150

6.  A novel tumor suppressor role of myosin light chain kinase splice variants through downregulation of the TEAD4/CD44 axis.

Authors:  Yen-Ju Huang; Tsung-Chun Lee; Yu-Chen Pai; Been-Ren Lin; Jerrold R Turner; Linda Chia-Hui Yu
Journal:  Carcinogenesis       Date:  2021-07-16       Impact factor: 4.944

7.  Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Srinivas Veerla; Mats Jönsson; Inge Bernstein; Ake Borg; Mef Nilbert
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

8.  Circumvent the uncertainty in the applications of transcriptional signatures to tumor tissues sampled from different tumor sites.

Authors:  Jun Cheng; You Guo; Qiao Gao; Hongdong Li; Haidan Yan; Mengyao Li; Hao Cai; Weicheng Zheng; Xiangyu Li; Weizhong Jiang; Zheng Guo
Journal:  Oncotarget       Date:  2017-05-02

Review 9.  Familial Colorectal Cancer Type X.

Authors:  Diana Bregner Zetner; Marie Luise Bisgaard
Journal:  Curr Genomics       Date:  2017-08       Impact factor: 2.236

10.  MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.

Authors:  Xiang Tan; Mingwu Chen
Journal:  Tumour Biol       Date:  2014-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.